This systematic review examines oral supplementation for melasma treatment outcomes, suggesting potential enhancement in efficacy through various supplements.
Background: Melasma treatment poses a significant challenge due to its propensity for relapse despite initial clearance success. Given this, there are three important pillars: topical treatment, oral medication, and treatment with energy-based devices. Purpose: This systematic review aimed to investigate the efficacy of various oral supplementation regimens in improving treatment outcomes for melasma. Methods: Employing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic literature search spanning December 2023 to May 2024 was conducted. Seventeen studies meeting inclusion criteria underwent rigorous analysis. Results: The review encompassed 17 articles, examining a range of supplements including Polypodium leucotomos , glutathione, probiotics, tomato extract, pycnogenol, red orange extract, astaxanthin, coenzyme Q10, collagen hydrolysate, and pomegranate extract. Conclusion: The findings underscore the potential benefits of these supplements in conjunction with conventional treatments for melasma, emphasizing the need for continued investigation and clinical validation.
No takes yet. Share an insight, caveat, or question.
Ana-Lorena Gonzalez-Botello (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: